Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Miromatrix Medical
company
About
Miromatrix Medical is engaged in the development of fully biological human organs and organ-derived biological products.
- 51 - 100
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1M
- Industries
- Biotechnology,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2009
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. It was founded in 2009 and is based in Eden Prairie, Minnesota.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1M
Miromatrix Medical has raised a total of
$1M
in funding over 2 rounds. Their latest funding was raised on
Jul 29, 2013 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 29, 2013 | Grant | $1M | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Miromatrix Medical is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
